AlphaYou
Overview
Key stats
Fundamentals Sep 9- Open
- $24.00
- 52-wk high
- $35.20
- High
- $24.96
- 52-wk low
- $14.19
- Low
- $23.95
- Prev close
- $24.82
- Mkt cap
- $7.01B
- P/E
- 2.6x
- Volume
- 3.15M
- Fwd P/E
- 34.4x
- P/S
- 7.1x
- P/B
- 12.0x
- Profit margin
- +10.6%
- Op margin
- +10.2%
- ROE
- +20.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in $0.53 a share below what analysts expected.
Earnings per share
-$0.01 expected
What the street expects next
EPS expected
$0.00 to $0.07
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $216.8M | $292.9M | $216.2M | $263.7M |
| Cost of what it sold | $69.3M | $72.0M | $74.8M | $84.1M |
| Gross profit | $147.5M | $220.9M | $141.3M | $179.6M |
| What it spent | ||||
| Research and development | $21.6M | $31.8M | $5.4M | $32.4M |
| Sales and admin | $52.0M | $56.5M | $59.7M | $66.5M |
| Other operating costs | $41.3M | $44.2M | $71.0M | $53.8M |
| Total operating expenses | $114.9M | $132.5M | $136.1M | $152.7M |
| What was left | ||||
| Operating profit | $32.6M | $88.4M | $5.3M | $26.9M |
| Interest on debt | $13.5M | $11.4M | $12.8M | $9.2M |
| Profit before tax | $24.3M | $82.0M | -$644.0K | -$614.0K |
| Tax | — | — | -$134.0K | $23.0K |
| Net profit | $24.3M | $82.0M | -$510.0K | -$637.0K |
| EBITDA | $42.7M | $97.6M | $17.2M | $15.2M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Moore Capital Management LP Makes New Investment in Caris Life Sciences, Inc. $CAI
NeutralSep 1Deutsche Bank AG Purchases New Position in Caris Life Sciences, Inc. $CAI
Leans bullishSep 1BlackRock Inc. Acquires New Stake in Caris Life Sciences, Inc. $CAI
Leans bullishAug 30Canada Pension Plan Investment Board Purchases Shares of 1,374,952 Caris Life Sciences, Inc. $CAI
BullishAug 29Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Rating of "Moderate Buy" from Brokerages
BullishAug 29PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAI
Leans bullishAug 27Caris Life Sciences (NASDAQ:CAI) Trading Down 6.2% - What's Next?
Leans bearishAug 26Maxi Investments CY Ltd Makes New $3.75 Million Investment in Caris Life Sciences, Inc. $CAI
BullishAug 25
Macro
35 macro signals shaping CAI right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results